Neurotransmitter transporters are responsible for removal of biogenic amine neurotransmitters after release into the synapse. These transporters are the targets for many clinically relevant drugs, such as antidepressants and psychostimulants. A high resolution crystal structure for the monoamine transporters has yet to be solved. We have developed a homology model for the serotonin transporter (SERT) based on the crystal structure of the leucine transporter (LeuT Aa ) from Aquifex aeolicus. The objective of the present studies is to identify the structural determinants forming the entrance to the substrate permeation pathway based on predictions from the SERT homology model. Using the substituted cysteine accessibility method, we identified residues predicted to reside at the entrance to the substrate permeation pathway that were reactive with methanethiosulfonate (MTS) reagents. Of these residues, Gln 332 in transmembrane helix (TMH) VI was protected against MTS inactivation in the presence of serotonin. Surprisingly, the reactivity of Gln 332 to MTS reagents was enhanced in the presence of cocaine. Bifunctional MTS cross-linkers also were used to examine the distances between helices predicted to form the entrance into the substrate and ion permeation pathway. Our studies suggest that substrate and ligand binding may induce conformational shifts in TMH I and/or VI, providing new opportunities to refine existing homology models of SERT and related monoamine transporters.
The serotonin (5-hydroxytryptamine (5-HT)2 ) transporter (SERT) is a member of the neurotransmitter sodium symporters (NSSs) (also referred as Na ϩ /Cl Ϫ -dependent transporters), whose function is to return 5-HT into presynaptic neurons after release into the synapse (1-3). Other family members include the transporters for dopamine (DAT), norepinephrine, ␥-aminobutyric acid, and glycine (1-4). These transporters are of particular interest as targets for many drugs, including antidepressants, anticonvulsants, and abused psychostimulants, such as cocaine and amphetamines (3). Although these transporters may share a common topology of 12 transmembrane ␣-helices (TMHs), intracellular N and C termini, and a large extracellular loop between TMHs III and IV with putative glycosylation sites, actual structural information for these proteins is limited.A high resolution crystal structure for members of the human neurotransmitter transporter family has yet to be solved, impeding the study of these important drug targets. A breakthrough came when the crystal structure of a bacterial homologue of Na ϩ /Cl Ϫ -dependent neurotransmitter transporters was determined (5). The leucine transporter (LeuT Aa ) from the bacteria Aquifex aeolicus was crystallized with the substrate and two Na ϩ ions occluded in the structure (5). It shares 20 -25% of overall sequence identity with the eukaryotic neurotransmitter transporters, including clusters of high sequence conservation (5). Our group and others have supported the use of LeuT Aa as an appropriate template for ho...